Dr. Devin Matthew Cunning, MD

Dr. Cunning practices at Arizona Coast Ear, Nose & Throat, Ltd. in Lake Havasu City, Arizona.

Dr. Cunning's NPI, 1629035944, was assigned on April 28, 2006. Dr. Cunning graduated from Medical College Of Wisconsin in 1992. Dr. Cunning holds Arizona license 27267.

Dr. Cunning's primary practice is Arizona Coast Ear, Nose & Throat, Ltd., at 1760 McCulloch N Blvd, Lake Havasu City, AZ 86403 in Mohave County. The practice phone is (928) 854-5368.

Dr. Cunning's primary practice is Arizona Coast Ear, Nose & Throat, Ltd. in Lake Havasu City, Arizona. Dr. Cunning is also affiliated with Havasu Regional Medical Center. The medical group on file is Arizona Coast Ear, Nose & Throat, Ltd. Dmand AI also links Dr. Cunning to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cunning practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Cunning's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Cunning is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Cunning's licenses on file in 4 states: Arizona, California, Pennsylvania and New York.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Cunning treats.

CMS data shows 10,822 Medicare services from Dr. Cunning across 35 procedure codes in 2024, for 1,750 Medicare patients. Medicare paid $432,010 for them.

CMS counts 1,750 Medicare patients who saw Dr. Cunning in 2024. The largest group is 65 to 74, with 797 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cunning's median patient age at 69, with 50% women.

In 2024, Dr. Cunning wrote 806 Medicare Part D claims for 293 patients. 79% of them were for generic drugs. CMS names the drug for 663 of them, across 16 drugs with 11 or more claims each, at $76,252 in total drug cost. In 2023, CMS named 587 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Cunning for performance year 2024, reported individually. Dr. Cunning accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cunning as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Cunning in 2023. The most frequent topics are Tomography, X-Ray Computed. Dr. Cunning's most frequent co-author is Randal S. Weber, MD.

CMS Open Payments shows 233 general payments to Dr. Cunning from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Inspire Medical Systems, Inc. paid the most, $7,714. It also lists 2 research payments totaling $3,450 in 2025.

Dr. Cunning graduated from Medical College Of Wisconsin in 1992. Dr. Cunning is a member of NHS, AASM, ACS and Association of American Physicians and Surgeons.

Dr. Cunning is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.